Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections?

J Med Virol. 2022 Aug;94(8):3515-3516. doi: 10.1002/jmv.27802. Epub 2022 Apr 28.

Authors

Massimiliano Lanzafame¹, Enrico Gibbin², Emanuela Lattuada², Sandro Vento³

Affiliations

¹ Department of Medical, Infectious Diseases Unit, Santa Chiara Hospital, Trento, Italy.
² Department of Multi-specialist, Infectious Diseases Unit, Santa Maria Della Misericordia Hospital, Rovigo, Italy.
³ Faculty of Medicine, University of Puthisastra, Phnom Penh, Cambodia.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal / therapeutic use
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
Vaccination

Substances

Antibodies, Monoclonal
COVID-19 Vaccines

Supplementary concepts

COVID-19 breakthrough infections